GL1X · GenesisL1 explorer

Research workbench

Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-937

Analyse Crystal structure of T. brucei pde-B1 catalytic domain with inhibitor npd-937 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5L8Y
Type
protein
Length
665 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphodiesterase
EC
3.1.4.-
UniProt
Q8WQX9
Ligands
GAI, CVA, ZN, MG
Pockets
2 · best druggability 0.74

Structure

x-ray diffraction · 2 distinct chains · 71% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphodiesterase (EC 3.1.4.-)protein33371% helix, 0% strandQ8WQX9
BPhosphodiesterase (EC 3.1.4.-)protein33271% helix, 0% strandQ8WQX9

Ligands and binding sites

  • GAI · Guanidine · ligand · chains A
  • CVA · 2-[(4-{5-[(4ar,8as)-3-cycloheptyl-4-oxo-3,4,4A,5,8,8A-hexahydrophthalazin-1-yl]-2-methoxyphenyl}phenyl) formamido]-N-(2-hydroxyethyl)acetamide · ligand · chains B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • MG · Magnesium ion · metal · 2 copies · chains A, B
  • FMT · Formic acid · additive · chains A
  • GOL · Glycerol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16280.740.8068MG, CVA
25110.720.8147MG

Interfaces

1 interface between chains.

  • A–B · 706 Ų buried · 4 hydrogen bonds · protein-protein

Compared structures

  • 5L8Y · Crystal structure of T. brucei PDE-B1 catalytic domain with inhibitor NPD-937 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.